Company
Cabaletta Bio, Inc. (CABA)
Standardized SEC financial data for Cabaletta Bio, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001759138 · NASDAQ · Biological Products, (No Diagnostic Substances).
Return on equity
-149.8%
Free cash flow
-$132.3M
Current ratio
2.77×
EPS (diluted)
$-2.10
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $21.4M | $32.5M | $39.3M | $55.4M | $97.2M | $142.7M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $108.7M | $122.2M | $106.5M | $241.2M | $164.0M | $133.6M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$26.8M | -$34.1M | -$46.4M | -$53.5M | -$88.2M | -$131.1M |
| Capital expenditures |
Get CABA data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/CABA/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/CABA/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"